In addition to cancer diagnosis, microbiome signatures also differ among tumor stages, tumor grades, cancer scores [60, 81], gene mutations (such as estrogen, progesterone receptors, and Her2) [156] or regions [157]. This evidence concerns the gene ERBB2 and neoplasm.